0001145549-20-015485.txt : 20200316 0001145549-20-015485.hdr.sgml : 20200316 20200316131457 ACCESSION NUMBER: 0001145549-20-015485 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200316 DATE AS OF CHANGE: 20200316 EFFECTIVENESS DATE: 20200316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVESTMENT CO OF AMERICA CENTRAL INDEX KEY: 0000051931 IRS NUMBER: 951426645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-00116 FILM NUMBER: 20716428 BUSINESS ADDRESS: STREET 1: 333 S HOPE ST - 55TH FL (MICG) CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: 213-486-9200 MAIL ADDRESS: STREET 1: 333 S HOPE ST - 55TH FL (MICG) CITY: LOS ANGELES STATE: CA ZIP: 90071 0000051931 S000009597 INVESTMENT CO OF AMERICA C000026214 Class A AIVSX C000026215 Class R-1 RICAX C000026216 Class R-2 RICBX C000026217 Class R-3 RICCX C000026218 Class R-4 RICEX C000026219 Class R-5 RICFX C000026221 Class C AICCX C000026222 Class F-1 AICFX C000026223 Class 529-A CICAX C000026225 Class 529-C CICCX C000026226 Class 529-E CICEX C000026227 Class 529-F-1 CICFX C000068572 Class F-2 ICAFX C000077857 Class R-6 RICGX C000148444 Class R-2E RIBEX C000164820 Class R-5E RICHX C000180008 Class F-3 FFICX C000189430 Class 529-T TIACX C000189431 Class T TICAX N-CEN 1 primary_doc.xml X0201 N-CEN LIVE 0000051931 XXXXXXXX true false false N-1A true INVESTMENT CO OF AMERICA 811-00116 0000051931 ESMT10R1J5REBJX2N406 333 South Hope Street 55th Floor Los Angeles 90071 US-CA US 9499755000 Capital Research and Management Company 6455 Irvine Center Drive Irvine 92618 9499755000 Fund accounting and transaction settlement records N N N-1A 1 Y James G. Ellis N/A N James Terrile N/A Y John C. Mazziotta N/A N Kathy J. Williams N/A N Kenneth M. Simril N/A N Mary Anne Dolan N/A N Pablo R. Gonzalez Guajardo N/A N William R. McLaughlin N/A N William D. Jones N/A N William L. Robbins N/A Y Russell C. Lemley N/A 333 South Hope Street 55th Floor Los Angeles 90071 XXXXXX N N N N N N American Funds Distributors, Inc. 8-17168 000006247 N/A Y N DELOITTE and TOUCHE LLP 00034 N/A N N N N N N N INVESTMENT CO OF AMERICA S000009597 ESMT10R1J5REBJX2N406 N 19 0 0 N/A N N Y N JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 N N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) N N N N Capital Research and Management Company 801-8055 000110885 M02M7XSKLMK96MWKNF95 N American Funds Service Company 84-00316 N/A Y N N Refinitiv US LLC 213800HQORQAP68CJJ04 N Six Financial Information AG 506700D369548LQDC335 CH N Bloomberg L.P. 549300B56MD0ZC402L06 N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Virtu ITG Solutions Network, LLC N/A N Markit North America, Inc. 549300HLPTRASHS0E726 N N JPMorgan Chase Bank, N.A. N/A N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) JPMorgan Chase Bank, N.A. N/A TW N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) JPMorgan Chase Bank, N.A. N/A GB N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Royal Bank of Canada N/A CA N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) JPMorgan Bank S.A. N/A FR N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Deutsche Bank AG N/A DE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) JPMorgan Chase Bank, N.A. N/A HK N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) MUFG Bank, Ltd. N/A JP N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Standard Chartered Bank Korea Limited N/A KR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) JPMorgan Bank S.A. N/A NL N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) UBS Switzerland AG N/A CH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N American Funds Service Company 84-00316 SEC File number Y N N Capital Research and Management Company M02M7XSKLMK96MWKNF95 Y N N American Funds Distributors, Inc. 8-17168 000006247 N/A 0.0 Credit Suisse Group AG N/A N/A ANGGYXNX0JLX3X63JN86 CH 1125521.000000000000 Cowen and Company, LLC 8-22522-1 000007616 549300WR155U7DVMIW58 513790.000000000000 Goldman Sachs & Co. LLC 8-00129-1 000000361 FOR8UP27PHTHYVLBNG30 1056357.000000000000 UBS AG N/A N/A BFM8T61CT2L1QCEMIK50 CH 951960.000000000000 Citigroup Global Markets Inc. 8-08177-1 000007059 MBNUM2BPBDO7JBLYG310 852217.000000000000 J.P. Morgan Securities LLC 8-35008-1 000000079 ZBUT11V806EZRVTWT807 839879.000000000000 Bank of America 8-69787-1 000283942 B4TYDEB6GKMZO031MB27 827207.000000000000 Sanford Bernstein & Co. LLC 8-52942-1 000104474 549300I7JYZHT7D5CO04 575117.000000000000 Jefferies & Company Inc. 8-15074-1 000002347 58PU97L1C0WSRCWADL48 567282.000000000000 Morgan Stanley & Co. LLC 8-15869-1 000008209 9R7GPTSO7KV3UQJZQ078 532029.000000000000 13809009.000000000000 Citigroup Global Markets Inc. 8-08177-1 000007059 MBNUM2BPBDO7JBLYG310 1373948739.000000000000 Wells Fargo Securities, LLC 8-65876-1 000126292 VYVVCKR63DVZZN70PB21 212621274.000000000000 Nomura/Instinet Group 8-23669-1 000007897 OXTKY6Q8X53C9ILVV871 1136207201.000000000000 J.P. Morgan Securities LLC 8-35008-1 000000079 ZBUT11V806EZRVTWT807 912498214.000000000000 Bank of America 8-69787-1 000283942 B4TYDEB6GKMZO031MB27 660937784.000000000000 Goldman Sachs & Co. LLC 8-00129-1 000000361 FOR8UP27PHTHYVLBNG30 550874956.000000000000 Barclays Bank PLC N/A N/A G5GSEF7VJP5I7OUK5573 GB 547774777.000000000000 Mizuho Bank, Ltd. N/A N/A RB0PEZSDGCO3JS6CEU02 JP 453921230.000000000000 BNP Paribas N/A N/A R0MUWSFPU8MPRO8K5P83 FR 404201831.000000000000 Amherst Pierpont Securities LLC 8-68282-1 000150696 549300LGG2RLWD21SU97 301235185.000000000000 8150071520.000000000000 Y 95322812457.000000000000 Uncommitted 1500000000.000000000000 N N N N true INTERNAL CONTROL RPT 2 internalcontrolica.htm ICA INTERNAL CONTROL REPORT 12/31/2019

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Trustees of The Investment Company of America:

In planning and performing our audit of the financial statements of The Investment Company of America (the “Fund”) as of and for the year ended December 31, 2019, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and Trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a fund’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls for safeguarding securities, that we consider to be a material weakness, as defined above, as of December 31, 2019.

This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ Deloitte & Touche LLP

Costa Mesa, California

February 6, 2020